C2ORF86 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.347840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.129600E-01
Normal-vs-Stage2
1.051980E-01
Normal-vs-Stage3
3.319700E-02
Normal-vs-Stage4
9.789400E-01
Stage1-vs-Stage2
7.172800E-01
Stage1-vs-Stage3
1.867790E-01
Stage1-vs-Stage4
1.351840E-01
Stage2-vs-Stage3
3.385200E-01
Stage2-vs-Stage4
6.558200E-02
Stage3-vs-Stage4
7.919800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.194780E-01
Normal-vs-AfricanAmerican
3.519600E-01
Normal-vs-Asian
1.321700E-02
Caucasian-vs-AfricanAmerican
7.053400E-01
Caucasian-vs-Asian
2.247900E-02
AfricanAmerican-vs-Asian
9.222300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.465790E-01
Normal-vs-Female
1.357850E-01
Male-vs-Female
8.908200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.148210E-01
Normal-vs-Age(41-60Yrs)
3.268400E-01
Normal-vs-Age(61-80Yrs)
9.970200E-02
Normal-vs-Age(81-100Yrs)
2.472100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.706200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.365400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.361800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.664120E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.045620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.627400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.552400E-02
Normal-vs-Daily Drinker
5.976100E-03
Normal-vs-Weekly Drinker
6.009500E-02
Normal-vs-Occasional Drinker
4.600800E-01
Normal-vs-Social Drinker
5.515400E-01
Non Drinker-vs-Daily Drinker
1.437230E-01
Non Drinker-vs-Weekly Drinker
8.720400E-01
Non Drinker-vs-Occasional Drinker
1.829430E-01
Non Drinker-vs-Social Drinker
2.808000E-01
Daily Drinker-vs-Weekly Drinker
2.476800E-01
Daily Drinker-vs-Occasional Drinker
2.891700E-02
Daily Drinker-vs-Social Drinker
6.391700E-02
Weekly Drinker-vs-Occasional Drinker
2.316600E-01
Weekly Drinker-vs-Social Drinker
2.585600E-01
Occasional Drinker-vs-Social Drinker
9.436200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.345600E-01
Normal-vs-Grade 2
6.445700E-02
Normal-vs-Grade 3
7.233900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.759800E-01
Grade 1-vs-Grade 3
2.913800E-01
Grade 1-vs-Grade 4
2.345600E-01
Grade 2-vs-Grade 3
3.029400E-01
Grade 2-vs-Grade 4
6.445700E-02
Grade 3-vs-Grade 4
7.233900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.970200E-02
Normal-vs-NonDiabetic
1.136450E-01
Diabetic-vs-NonDiabetic
8.783600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.572400E-02
Normal-vs-NoPancreatitis
1.282580E-01
Pancreatitis-vs-NoPancreatitis
4.254200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.638800E-01
Normal-vs-N1
1.055430E-01
N0-vs-N1
6.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.901380E-01
Normal-vs-TP53-NonMutant
2.443800E-01
TP53-Mutant-vs-TP53-NonMutant
7.980600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
